Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game?

被引:0
|
作者
Chen, Jacki [1 ,2 ]
Tu, Thomas [3 ]
Cohen, Chari [4 ]
Wang, Su [4 ,5 ]
Hsu, Yao-Chun [6 ,7 ]
Gish, Robert G. [4 ,8 ,9 ,10 ]
机构
[1] Taiwan Hepatitis Informat & Care Assoc, Kaohsiung, Taiwan
[2] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ USA
[3] Univ Sydney, Westmead Inst Med Res, Storr Liver Ctr, Westmead Hosp, Westmead, NSW, Australia
[4] Hepatitis B Fdn, Doylestown, PA USA
[5] RWJBarnabas Rutgers Med Grp, Ctr Asian Hlth, Cooperman Barnabas Med Ctr, Livingston, NJ USA
[6] E Da Hosp, Div Gastroenterol & Hepatol, Kaohsiung, Taiwan
[7] I Shou Univ, Coll Med, Sch Med, Kaohsiung, Taiwan
[8] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA USA
[9] Univ Nevada, Reno Sch Med, Reno, NV USA
[10] Robert G Gish Consultants LLC, 6022 La Jolla Mesa Dr, La Jolla, CA 92037 USA
关键词
D O I
10.1097/HEP.0000000000000732
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:E132 / E133
页数:2
相关论文
共 50 条
  • [1] Reply: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game?
    Jeng, Wen-Juei
    Chien, Rong-Nan
    Liaw, Yun-Fan
    HEPATOLOGY, 2024, 79 (05) : E134 - E135
  • [2] Antiviral therapy in patients with chronic hepatitis B and cirrhosis
    Lai, CJ
    Terrault, NA
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (03) : 629 - +
  • [3] Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis
    Jeng, Wen-Juei
    Liaw, Yun-Fan
    SEMINARS IN LIVER DISEASE, 2021, 41 (03) : 349 - 357
  • [4] Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis
    Okada, Masako
    Enomoto, Masaru
    Kawada, Norifumi
    Nguyen, Mindie H.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (12) : 1095 - 1104
  • [5] Chronic hepatitis B with advanced fibrosis or cirrhosis: Impact of antiviral therapy
    Arora, Gaurav
    Keeffe, Emmet B.
    REVIEWS IN GASTROENTEROLOGICAL DISORDERS, 2007, 7 (02) : 63 - 73
  • [7] ANTIVIRAL THERAPY FOR THE PREVENTION OF LONG-TERM CIRRHOSIS RISK IN PATIENTS WITH CHRONIC HEPATITIS B
    Yang, H. -I.
    Hoang, J.
    Lin, D.
    Liu, J.
    Hu, H. -H.
    Lee, M. -H.
    Nguyen, N. H.
    Kim, Y.
    Jen, C. -L.
    Vu, V.
    Le, A.
    Chaung, K.
    Nguyen, V.
    Trinh, H.
    Li, J.
    Zhang, J.
    Hsing, A.
    Chen, C. -J.
    Nguyen, M. H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S591 - S591
  • [8] Discontinuation of antiviral therapy in chronic hepatitis B patients
    Renato Medas
    Rodrigo Liberal
    Guilherme Macedo
    World Journal of Clinical Cases, 2021, (24) : 6979 - 6986
  • [9] Discontinuation of antiviral therapy in chronic hepatitis B patients
    Medas, Renato
    Liberal, Rodrigo
    Macedo, Guilherme
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (24) : 6979 - 6986
  • [10] Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis
    Gao, Xuesong
    Yang, Hwai-, I
    Trinh, Huy
    Jeong, Donghak
    Li, Jiayi
    Zhang, Jian
    Le, An
    Hoang, Joseph
    Nguyen, Pauline
    Henry, Linda
    Nguyen, Mindie H.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (09) : 1207 - 1211